Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE

Standard Dose
EQ 2% BASE;EQ 0.5% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is listed in Drugs@FDA under application 217260 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE;EQ 0.5% BASE Sponsor INGENUS PHARMS LLC Submission history Latest submission status date: 2023-05-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is listed in Drugs@FDA under application 217260 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 2% BASE;EQ 0.5% BASE Sponsor INGENUS PHARMS LLC Submission history Latest submission status date: 2023-05-01 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE) | Drug Monograph | MedicHelpline